MIOCHOL
LOE ApproachingNDAOPHTHALMICFOR SOLUTION
Approved
Oct 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
MIOCHOL by Novartis is clinical pharmacology acetylcholine is a naturally occurring neurohormone which mediates nerve impulse transmission at all cholinergic sites involving somatic and autonomic nerves. First approved in 1973.
Drug data last refreshed 6d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MIOCHOL is a direct-acting cholinergic agonist (acetylcholine) administered as an intraocular solution for ophthalmic use. It causes rapid miosis (pupil constriction) by mimicking acetylcholine at cholinergic receptors in the iris sphincter muscle. The drug is used during anterior segment eye surgery to produce and maintain miosis for improved surgical visualization and safety.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (score: 30/100), indicating shrinking market opportunity and potential team contraction.
Mechanism of Action
CLINICAL PHARMACOLOGY Acetylcholine is a naturally occurring neurohormone which mediates nerve impulse transmission at all cholinergic sites involving somatic and autonomic nerves. After release from the nerve ending, acetylcholine is rapidly inactivated by the enzyme acetylcholinesterase by…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on MIOCHOL offers limited career advancement in a declining product category; roles focus on defensive market management, cost optimization, and stakeholder retention rather than growth initiatives. The product's approaching loss of exclusivity and minimal clinical pipeline make it suitable for early-career professionals seeking operational experience or specialists in legacy product stewardship.
Brand Manager
Worked on MIOCHOL at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.